Consensus guidelines for the treatment of Nephrotic Syndrome in Children of Pakistan

Endorsed by Pakistan Pediatric Association- Nephrology Group

Avtorji

  • Ali Asghar A Lanewala Sindh Institute of Urology & Transplantation, Karachi
  • Seema Hashmi
  • veena Tresa Sindh Institute of Urology & Transplantation, Karachi
  • Sabeeta Khatri Sindh Institute of Urology & Transplantation, Karachi
  • Irshad Ali Bajeer Sindh Institute of Urology & Transplantation, Karachi
  • Afshan Ehsan Sindh Institute of Urology & Transplantation, Karachi
  • Khemchand N Moorani National Institute of Child Health (NICH) Jinnah Sindh Medical University (JSMU) Karachi
  • Sadaf Asim National Institute of Child Health (NICH) Jinnah Sindh Medical University (JSMU) Karachi
  • Bilquis Abro

DOI:

https://doi.org/10.53778/pjkd38101

Ključne besede:

pediatric, nephrotic syndrom, relapsing nephrotic syndrome, management, resistant nephrotic syndrome, rituximab, prednisolone, cyclosporine, tacrolimus, cyclophosphamide

Povzetek

This guideline was prepared for the pediatric nephrologists and the genral pediatrician to review the subject and update with the treatment of different manifestaion of childhood nephrotic syndrome.

Objavljeno

2021-02-07

Kako citirati

Consensus guidelines for the treatment of Nephrotic Syndrome in Children of Pakistan: Endorsed by Pakistan Pediatric Association- Nephrology Group. (2021). Pakistan Journal of Kidney Diseases, 3(8), 1-20. https://doi.org/10.53778/pjkd38101